Search research articles
Contact Us
Filters
Showing results (1-10 of 110) with videos related to
Page
of 11
Sort By:
Clinical Liver Disease
|
April 18, 2019
Diagnostic approach to renal failure in cirrhosis
Isabel Graupera, Andres Cardenas
Hepatology (Baltimore, Md.)
|
April 8, 2015
Hepatorenal syndrome: The last pieces of the puzzle or not yet?
Isabel Graupera, Pere Ginès
Journal of Hepatology
|
July 10, 2018
Screening is caring: Community-based non-invasive diagnosis and treatment strategies for hepatitis C to reduce liver disease burden
Isabel Graupera, Frank Lammert
Hepatology (Baltimore, Md.)
|
July 26, 2017
Reply
Càndid Villanueva, Isabel Graupera, Edilmar Alvarado
Medicina Clinica
|
July 29, 2017
Non-alcoholic fatty liver disease: A poorly known pandemic
Salvador Augustin, Isabel Graupera, Juan Caballeria, et al.
Expert Review of Gastroenterology & Hepatology
|
February 13, 2026
The role of endoscopic therapies for patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Joan Llach, Anna Soria, Isabel Graupera, et al.
Disease Markers
|
November 3, 2011
Prognostic markers in patients with cirrhosis and portal hypertension who have not bled
Maria Poca, Angela Puente, Isabel Graupera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 9, 2021
Reply
Octavi Bassegoda, Pol Olivas, Isabel Graupera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 5, 2022
Reply
Maja Thiele, Miquel Serra-Burriel, Isabel Graupera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 31, 2021
Reply
Octavi Bassegoda, Pol Olivas, Isabel Graupera, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 110) with videos related to
Sort By:
Page
of 11
Clinical Liver Disease
|
April 18, 2019
Diagnostic approach to renal failure in cirrhosis
Isabel Graupera, Andres Cardenas
Hepatology (Baltimore, Md.)
|
April 8, 2015
Hepatorenal syndrome: The last pieces of the puzzle or not yet?
Isabel Graupera, Pere Ginès
Journal of Hepatology
|
July 10, 2018
Screening is caring: Community-based non-invasive diagnosis and treatment strategies for hepatitis C to reduce liver disease burden
Isabel Graupera, Frank Lammert
Hepatology (Baltimore, Md.)
|
July 26, 2017
Reply
Càndid Villanueva, Isabel Graupera, Edilmar Alvarado
Medicina Clinica
|
July 29, 2017
Non-alcoholic fatty liver disease: A poorly known pandemic
Salvador Augustin, Isabel Graupera, Juan Caballeria, et al.
Expert Review of Gastroenterology & Hepatology
|
February 13, 2026
The role of endoscopic therapies for patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Joan Llach, Anna Soria, Isabel Graupera, et al.
Disease Markers
|
November 3, 2011
Prognostic markers in patients with cirrhosis and portal hypertension who have not bled
Maria Poca, Angela Puente, Isabel Graupera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 9, 2021
Reply
Octavi Bassegoda, Pol Olivas, Isabel Graupera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 5, 2022
Reply
Maja Thiele, Miquel Serra-Burriel, Isabel Graupera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 31, 2021
Reply
Octavi Bassegoda, Pol Olivas, Isabel Graupera, et al.
Page
of 11